The American Heart Association held its fully virtual 2021 Scientific Sessions November 13-15, 2021. Vanderbilt University Medical Center presenters included:
Soo Hyun (Esther) Kim, M.D.
It’s Not Always Atherosclerosis – Vascular Medicine Approach to Arteriopathy: 42-year-old Woman With Spontaneous Coronary Artery Dissection
Study Looks at Dantrolene for Ventricular Tachycardia
Four Dimensions of Heart Allocation Today
Unlocking Mechanisms for Extracellular RNA Transport
Christopher Ellis, M.D.
Importance of Left Atrial Appendage (LAA) for the Pathophysiology and Treatment of Atrial Fibrillation
Squaring Off: Amplatzer Amulet and Watchman 2.5 Both Emerge Winners
Interatrial Shunt Could Offer Heart Failure Relief
Expanding the Patient Pool for Micra AV
William Stevenson, M.D.
Advances in VT Ablation – Identifying Functional Aspects of VT Circuit
Study Looks at Dantrolene for Ventricular Tachycardia
Deepak Gupta, M.D.
Selective Phosphodiesterase-9 Inhibition with IMR-687 Mitigates Cardiac Hypertrophy and Renal Injury in Preclinical Mouse Models of Heart Failure with Preserved Ejection Fraction
Natriuretic Peptide Deficiency Uncovered
Dan Mark Roden, M.D.
Potential Impact of Virtual Longitudinal Studies Health Tech & Innovation (Panelist)
Uncovering the Unique Subtypes of Atrial Fibrillation
Preventing AFib Using a Novel Nutraceutical
Jane Freedman, M.D.
The Role of the Platelet in Mediating Cardiovascular Disease in SARS-CoV-2 Infection
Platelets Act as First Responders to COVID-19 and Flu
Lynne Stevenson, M.D.
An Abundance of Therapeutics – An Integrated Approach to Managing Heart Failure in Patients With Diabetes
Four Dimensions of Heart Allocation Today
A Pathway to Better Heart Failure Treatment
